参考资料: [1]Charles V Clark, Brian Pentland, David J Ewing, Basil F Clarke; Decreased Skin Wrinkling in Diabetes Mellitus. Diabetes Care 1 May 1984; 7 (3): 224–227. [2]Kamran, H., ...
The Food and Drug Administration (FDA) has approved Alyftrek ™ (vanzacaftor/tezacaftor/deutivacaftor) for the treatment of cystic fibrosis (CF) in patients aged 6 years and older who have at least one ...
BX-004 is under development for the treatment of cystic fibrosis, non-cystic fibrosis bronchiectasis and resistant pseudomonas aeruginosa infections. It is administered as inhalational formulation.